PATENT CLAIM ANALYSIS

Application Number: 16207545
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["424", "401000"]

Abstract:
A microcapsule composition comprising at least one polymer substantially disposed as a semi-permeable shell around an aqueous buffered solution and at least one agent, wherein the agent permeates the shell, and wherein the composition is suitable for delivery to a mammal.

Claim (Index 17):
The method of  claim 13 , wherein the buffer solution comprises: phosphate buffered saline which is a solution containing sodium chloride, sodium phosphate, or potassium chloride, or potassium phosphate; 3-([tris(hydroxymethyl)methyl]amino) propane-sulfonic acid (TAPS); N,N-bis(2-hydroxyethyl)glycine (Bicine); tris(hydroxyl-methyl)methylamine (Tris); N-tris(hydroxymethyl)methylglycine (Tricine); 3-[N-Tris-(hydroxymethyl)methylamino]-2-hydroxypropanesulfonic acid (TAPSO); 4-2-hydroxy-ethyl-1-piperazineethanesulfonic acid (HEPES); 2-([tris(hydroxymethyl)methyl]amino) ethanesulfonic acid (TES); 3-(N-morpholino)propanesulfonic acid (MOPS); piperazine-N,N\u2032-bis(2-ethanesulfonic acid) (PIPES); dimethylarsinic acid (Cacodylate); saline sodium citrate (SSC); 2-(N-morpholino)ethanesulfonic acid (IVIES); Phosphoric acid; citric acid; piperazine-N,N\u2032-bis(3-propanesulfonic acid (PIPPS); piperazine-N,N\u2032-bis(3-butanesulfonic acid) (PIPBS); N,N\u2032-Diethylethylenediamine-N,N\u2032-bis(3-propanesulfonic acid) (DESPEN); N,N\u2032-diethylpiperazine dihydrochloride (DEPP-2HCl); N,N,N\u2032,N\u2032-tetraethyl-ethylenediamine dihydrochloride (TEEN-2HCl); N-2-Acetamidoiminodiacetic acid (ADA); 1,3-Bis[tris(hydroxymethyl)methylamino]propane hydrochloride (BIS-TRIS propane-HCl); N-2-acetamido-2-aminoethanesulfonic acid (ACES); 3-(N-Morpholino)-2-hydroxypropane sulfonic acid (MOPSO); imidazole hydrochloride; 3-(N-morpholino)butanesulfonic acid (MOBS); 4-2-hydroxyethyl-1-piperazinepropane-sulfonic acid (HEPPS); N-tris(hydroxymethyl)methylglycine (TRICINE); glycine amide hydrochloride; Tris(hydroxymethyl)aminomethane hydrochloride (TRIS hydrochloride); glycylglycine; Boric acid; cyclohexylaminoethanesulfonic acid (CHES); 3-(Cyclohexylamino)propane sulfonic acid (CAPS); N,N,N\u2032,N\u2032-tetraethylmethylene-diamine dihydrochloride (TEMN- 2 HCl); HCl and sodium citrate; citric acid and sodium citrate; acetic acid and sodium acetate; K 2 HPO 4  and KH 2 PO 4 ; Na 2 HPO 4  and NaH 2 PO 4 ; N-cyclohexyl-2-aminoethanesulfonic acid; sodium borate; and sodium hydroxide.

Metadata:
- Claim Count in Document: 63.0
- Percentile: 98.0
- Lexical Diversity: 1.375
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15921350', '15921269', '13619128', '16207515', '15791554']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.769544258874398
- 35 USC 102 Novelty (BERT): 0.589496081900882
- Combined Prediction Score: 0.7515394411770464
- Mean Citation Score: 365.359248
- Max Citation Score: 477.3106
- Similarity Product: 465.06011757557394

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test